Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Tofacitinib helped psoriasis but not alopecia universalis, needing more research.

New markers can detect tumors, aid drug delivery, and treat cancer effectively and safely.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

A 3-year-old boy had a rare hairball condition usually seen in teenage girls.

Testosterone pellet therapy may better address hormone imbalances in aging by focusing on local hormone production and symptom relief.

Tofacitinib is more effective than traditional treatments for severe alopecia areata in children.

Antizyme reduces tumor growth and normalizes skin cell development affected by MEK.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Thymoma-associated multiorgan autoimmunity can cause liver damage and affects multiple organs, with limited treatment options and a generally poor prognosis.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

Blocking mTORC1 reduces skin tumor growth in mice.

The research developed new fortilin protein constructs for potential heart disease treatments.

Ruxolitinib reduced inflammation and improved symptoms in APECED patients but may cause anemia and weight gain.

Risankizumab effectively treats and maintains skin clearance in moderate-to-severe psoriasis.

The supplement did not work better than a placebo for hair loss in women over 60.

The method increased hair volume, thickened strands, and reduced hair loss.

Topical tofacitinib shows promise as a future treatment for alopecia areata.

Tofacitinib helped a teenager with severe hair loss grow hair back, but more research is needed.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

Tofacitinib may be safe and effective for treating certain skin conditions in children.

Midazolam reduces PTSD-like behavior in rats by acting on specific brain receptors.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

Combining medications is more effective for treating benign prostatic syndrome symptoms.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

Botulinum toxin A can help improve thin endometrium and embryo implantation.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.

ITK inhibitors may effectively treat alopecia areata.